the fact that drugs aren't approved on that basis doesn't make the question unrealistic
You are equating lack of evidence with evidence of lack - which is a logical fallacy so common it must have a name.
Find me a drug for a non-fatal disease that was submitted with two trials - one with p<0.01 and one with p between 0.05 and 0.10 - that was rejected in the last 3 years. Then I'll admit you might have a strong case.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.